Gastrointestinal (GI) tumors (cancers of the esophagus, gastric, liver, pancreas, colon, and
rectum) contribute to a large number of deaths worldwide. STAT3 is an oncogenic …

Colorectal cancer (CRC) ranks as the third most aggressive tumor globally, and it can be
categorized into two forms: colitis-mediated CRC and sporadic CRC. The therapeutic …

In recent decades, colorectal cancer (CRC) has turned into one of the most widespread
malignancies, and the incidence of this malignancy is expected to increase. Despite …

Cancer is one of the leading causes of morbidity and mortality worldwide. Significant
improvements in the modern era of anticancer therapeutic strategies have increased the …

Background: Bovine papillomatosis (BP) is considered the most common health problem in
large cattle farms. Aim: This study attempts to confirm clinically suspected BP in cattle by …

Purpose: Our research developed immune-related long noncoding RNAs (lncRNAs) for risk
stratification in cervical cancer (CC) and explored factors of prognosis, inflammatory …

Cancer consists of a group of diseases with the salient properties of an uncontrolled cell
cycle, metastasis, and evasion of the immune response, mainly driven by the genomic …

Niclosamide is a drug used to treat parasitic infections. Recent studies have shown that
niclosamide may have a wide range of clinical applications and can be used to treat cancer …

Colorectal cancer (CRC) is the third most prevalent cancer to be diagnosed, and it has a
substantial mortality rate. Despite numerous studies being conducted on CRC, it remains a …

Background. In recent years, a growing body of research has revealed that long noncoding
RNAs (lncRNAs) participate in regulating genomic instability. Materials and Methods. We …